Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 56 entries
Sorted by: Best Match Show Resources per page
Speaker Abstracts.

Drug metabolism reviews

[No authors listed]
PMID: 26436346
Drug Metab Rev. 2015;47:6-33. doi: 10.3109/03602532.2015.1071934. Epub 2015 Aug 27.

No abstract available.

Cite
Speaker Abstracts. Drug Metab Rev. 2015;47:6-33doi: 10.3109/03602532.2015.1071934.
(2015). Speaker Abstracts. Drug metabolism reviews, 476-33. https://doi.org/10.3109/03602532.2015.1071934
"Speaker Abstracts." Drug metabolism reviews vol. 47 (2015): 6-33. doi: https://doi.org/10.3109/03602532.2015.1071934
Speaker Abstracts. Drug Metab Rev. 2015;47:6-33. doi: 10.3109/03602532.2015.1071934. Epub 2015 Aug 27. PMID: 26436346.
Copy Download .nbib Format: NLM
20th North American ISSX Meeting.

Drug metabolism reviews

[No authors listed]
PMID: 27418302
Drug Metab Rev. 2016 Jul;48:6-20. doi: 10.1080/03602532.2016.1191845.

No abstract available.

Cite
20th North American ISSX Meeting. Drug Metab Rev. 2016;48:6-20doi: 10.1080/03602532.2016.1191845.
(2016). 20th North American ISSX Meeting. Drug metabolism reviews, 486-20. https://doi.org/10.1080/03602532.2016.1191845
"20th North American ISSX Meeting." Drug metabolism reviews vol. 48 (2016): 6-20. doi: https://doi.org/10.1080/03602532.2016.1191845
20th North American ISSX Meeting. Drug Metab Rev. 2016 Jul;48:6-20. doi: 10.1080/03602532.2016.1191845. PMID: 27418302.
Copy Download .nbib Format: NLM
Upcoming ISSX Meetings.

Drug metabolism reviews

[No authors listed]
PMID: 26247906
Drug Metab Rev. 2015;47:5. doi: 10.3109/03602532.2015.1071938. Epub 2015 Oct 02.

No abstract available.

Cite
Upcoming ISSX Meetings. Drug Metab Rev. 2015;47:5doi: 10.3109/03602532.2015.1071938.
(2015). Upcoming ISSX Meetings. Drug metabolism reviews, 475. https://doi.org/10.3109/03602532.2015.1071938
"Upcoming ISSX Meetings." Drug metabolism reviews vol. 47 (2015): 5. doi: https://doi.org/10.3109/03602532.2015.1071938
Upcoming ISSX Meetings. Drug Metab Rev. 2015;47:5. doi: 10.3109/03602532.2015.1071938. Epub 2015 Oct 02. PMID: 26247906.
Copy Download .nbib Format: NLM
Xenobiotic-metabolizing enzymes in plants and their role in uptake and biotransformation of veterinary drugs in the environment.

Drug metabolism reviews

Bártíková H, Skálová L, Stuchlíková L, Vokřál I, Vaněk T, Podlipná R.
PMID: 26275109
Drug Metab Rev. 2015 Aug 14;1-14. Epub 2015 Aug 14.

Many various xenobiotics permanently enter plants and represent potential danger for their organism. For that reason, plants have evolved extremely sophisticated detoxification systems including a battery of xenobiotic-metabolizing enzymes. Some of them are similar to those in humans and...

Cite
Bártíková H, Skálová L, Stuchlíková L, et al. Xenobiotic-metabolizing enzymes in plants and their role in uptake and biotransformation of veterinary drugs in the environment. Drug Metab Rev. 2015;1-14
Bártíková, H., Skálová, L., Stuchlíková, L., Vokřál, I., Vaněk, T., & Podlipná, R. (2015). Xenobiotic-metabolizing enzymes in plants and their role in uptake and biotransformation of veterinary drugs in the environment. Drug metabolism reviews, 1-14.
Bártíková, Hana, et al. "Xenobiotic-metabolizing enzymes in plants and their role in uptake and biotransformation of veterinary drugs in the environment." Drug metabolism reviews vol. (2015): 1-14.
Bártíková H, Skálová L, Stuchlíková L, Vokřál I, Vaněk T, Podlipná R. Xenobiotic-metabolizing enzymes in plants and their role in uptake and biotransformation of veterinary drugs in the environment. Drug Metab Rev. 2015 Aug 14;1-14. Epub 2015 Aug 14. PMID: 26275109.
Copy Download .nbib Format: NLM
Special issue: nanotechnology and disease.

Drug metabolism reviews

Biris AS, Radominska-Pandya A.
PMID: 24678874
Drug Metab Rev. 2014 May;46(2):127. doi: 10.3109/03602532.2014.903061. Epub 2014 Mar 28.

No abstract available.

Cite
Biris AS, Radominska-Pandya A. Special issue: nanotechnology and disease. Drug Metab Rev. 2014;46(2):127doi: 10.3109/03602532.2014.903061.
Biris, A. S., & Radominska-Pandya, A. (2014). Special issue: nanotechnology and disease. Drug metabolism reviews, 46(2), 127. https://doi.org/10.3109/03602532.2014.903061
Biris, Alexandru S, and Radominska-Pandya, Anna. "Special issue: nanotechnology and disease." Drug metabolism reviews vol. 46,2 (2014): 127. doi: https://doi.org/10.3109/03602532.2014.903061
Biris AS, Radominska-Pandya A. Special issue: nanotechnology and disease. Drug Metab Rev. 2014 May;46(2):127. doi: 10.3109/03602532.2014.903061. Epub 2014 Mar 28. PMID: 24678874.
Copy Download .nbib Format: NLM
Metabolism, pharmacokinetics, and toxicokinetics defined.

Drug metabolism reviews

Di Carlo FJ.
PMID: 7084027
Drug Metab Rev. 1982;13(1):1-4. doi: 10.3109/03602538209002228.

No abstract available.

Cite
Di Carlo FJ. Metabolism, pharmacokinetics, and toxicokinetics defined. Drug Metab Rev. 1982;13(1):1-4doi: 10.3109/03602538209002228.
Di Carlo, F. J. (1982). Metabolism, pharmacokinetics, and toxicokinetics defined. Drug metabolism reviews, 13(1), 1-4. https://doi.org/10.3109/03602538209002228
Di Carlo, F J. "Metabolism, pharmacokinetics, and toxicokinetics defined." Drug metabolism reviews vol. 13,1 (1982): 1-4. doi: https://doi.org/10.3109/03602538209002228
Di Carlo FJ. Metabolism, pharmacokinetics, and toxicokinetics defined. Drug Metab Rev. 1982;13(1):1-4. doi: 10.3109/03602538209002228. PMID: 7084027.
Copy Download .nbib Format: NLM
Refined CYP2E1.

Drug metabolism and pharmacokinetics

Yamazoe Y, Murayama N, Yoshinari K.
PMID: 34673327
Drug Metab Pharmacokinet. 2021 Dec;41:100413. doi: 10.1016/j.dmpk.2021.100413. Epub 2021 Aug 19.

A Template system for a prediction of human CYP2E1-mediated reactions (Drug Metab Rev 2011) has been refined with the introduction of ideas of Trigger-residue and the residue-initiated movement of ligands in the active site. The refined system also includes...

Cite
Yamazoe Y, Murayama N, Yoshinari K. Refined CYP2E1. Drug Metab Pharmacokinet. 2021;41:100413doi: 10.1016/j.dmpk.2021.100413.
Yamazoe, Y., Murayama, N., & Yoshinari, K. (2021). Refined CYP2E1. Drug metabolism and pharmacokinetics, 41100413. https://doi.org/10.1016/j.dmpk.2021.100413
Yamazoe, Yasushi, et al. "Refined CYP2E1." Drug metabolism and pharmacokinetics vol. 41 (2021): 100413. doi: https://doi.org/10.1016/j.dmpk.2021.100413
Yamazoe Y, Murayama N, Yoshinari K. Refined CYP2E1. Drug Metab Pharmacokinet. 2021 Dec;41:100413. doi: 10.1016/j.dmpk.2021.100413. Epub 2021 Aug 19. PMID: 34673327.
Copy Download .nbib Format: NLM
Refined CYP2E1.

Drug metabolism and pharmacokinetics

Yamazoe Y, Murayama N, Yoshinari K.
PMID: 34673327
Drug Metab Pharmacokinet. 2021 Aug 19;41:100413. doi: 10.1016/j.dmpk.2021.100413. Epub 2021 Aug 19.

A Template system for a prediction of human CYP2E1-mediated reactions (Drug Metab Rev 2011) has been refined with the introduction of ideas of Trigger-residue and the residue-initiated movement of ligands in the active site. The refined system also includes...

Cite
Yamazoe Y, Murayama N, Yoshinari K. Refined CYP2E1. Drug Metab Pharmacokinet. 2021;41:100413doi: 10.1016/j.dmpk.2021.100413.
Yamazoe, Y., Murayama, N., & Yoshinari, K. (2021). Refined CYP2E1. Drug metabolism and pharmacokinetics, 41100413. https://doi.org/10.1016/j.dmpk.2021.100413
Yamazoe, Yasushi, et al. "Refined CYP2E1." Drug metabolism and pharmacokinetics vol. 41 (2021): 100413. doi: https://doi.org/10.1016/j.dmpk.2021.100413
Yamazoe Y, Murayama N, Yoshinari K. Refined CYP2E1. Drug Metab Pharmacokinet. 2021 Aug 19;41:100413. doi: 10.1016/j.dmpk.2021.100413. Epub 2021 Aug 19. PMID: 34673327.
Copy Download .nbib Format: NLM
International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019-2020 concluding remarks.

Drug metabolism reviews

Schleiff MA, Sodhi JK.
PMID: 33836131
Drug Metab Rev. 2021 May;53(2):279-284. doi: 10.1080/03602532.2021.1910293. Epub 2021 Apr 09.

The International Society for the Study of Xenobiotics (ISSX) New Investigators Group has assembled a global team of emerging scientists to collaboratively compose a series of articles whose topics span the broad field of drug metabolism and will guide...

Cite
Schleiff MA, Sodhi JK. International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019-2020 concluding remarks. Drug Metab Rev. 2021;53(2):279-284doi: 10.1080/03602532.2021.1910293.
Schleiff, M. A., & Sodhi, J. K. (2021). International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019-2020 concluding remarks. Drug metabolism reviews, 53(2), 279-284. https://doi.org/10.1080/03602532.2021.1910293
Schleiff, Mary A, and Sodhi, Jasleen K. "International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019-2020 concluding remarks." Drug metabolism reviews vol. 53,2 (2021): 279-284. doi: https://doi.org/10.1080/03602532.2021.1910293
Schleiff MA, Sodhi JK. International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019-2020 concluding remarks. Drug Metab Rev. 2021 May;53(2):279-284. doi: 10.1080/03602532.2021.1910293. Epub 2021 Apr 09. PMID: 33836131.
Copy Download .nbib Format: NLM
Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition.

Drug metabolism reviews

Chen J, Liu J, Huang Y, Li R, Ma C, Zhang B, Wu F, Yu W, Zuo X, Liang Y, Wang Q.
PMID: 33905669
Drug Metab Rev. 2021 Nov;53(4):491-507. doi: 10.1080/03602532.2021.1917598. Epub 2021 Apr 27.

Herbal plants typically have complex compositions and diverse mechanisms. Among them, bioactive constituents with relatively high exposure

Cite
Chen J, Liu J, Huang Y, et al. Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition. Drug Metab Rev. 2021;53(4):491-507doi: 10.1080/03602532.2021.1917598.
Chen, J., Liu, J., Huang, Y., Li, R., Ma, C., Zhang, B., Wu, F., Yu, W., Zuo, X., Liang, Y., & Wang, Q. (2021). Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition. Drug metabolism reviews, 53(4), 491-507. https://doi.org/10.1080/03602532.2021.1917598
Chen, Junmei, et al. "Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition." Drug metabolism reviews vol. 53,4 (2021): 491-507. doi: https://doi.org/10.1080/03602532.2021.1917598
Chen J, Liu J, Huang Y, Li R, Ma C, Zhang B, Wu F, Yu W, Zuo X, Liang Y, Wang Q. Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition. Drug Metab Rev. 2021 Nov;53(4):491-507. doi: 10.1080/03602532.2021.1917598. Epub 2021 Apr 27. PMID: 33905669.
Copy Download .nbib Format: NLM
Novel advances in biotransformation and bioactivation research - 2020 year in review.

Drug metabolism reviews

Khojasteh SC, Argikar UA, Driscoll JP, Heck CJS, King L, Jackson KD, Jian W, Kalgutkar AS, Miller GP, Kramlinger V, Rietjens IMCM, Teitelbaum AM, Wang K, Wei C.
PMID: 33910427
Drug Metab Rev. 2021 Aug;53(3):384-433. doi: 10.1080/03602532.2021.1916028. Epub 2021 Jun 24.

This annual review is the sixth of its kind since 2016 (see references). Our objective is to explore and share articles which we deem influential and significant in the field of biotransformation and bioactivation. These fields are constantly evolving...

Cite
Khojasteh SC, Argikar UA, Driscoll JP, et al. Novel advances in biotransformation and bioactivation research - 2020 year in review. Drug Metab Rev. 2021;53(3):384-433doi: 10.1080/03602532.2021.1916028.
Khojasteh, S. C., Argikar, U. A., Driscoll, J. P., Heck, C. J. S., King, L., Jackson, K. D., Jian, W., Kalgutkar, A. S., Miller, G. P., Kramlinger, V., Rietjens, I. M. C. M., Teitelbaum, A. M., Wang, K., & Wei, C. (2021). Novel advances in biotransformation and bioactivation research - 2020 year in review. Drug metabolism reviews, 53(3), 384-433. https://doi.org/10.1080/03602532.2021.1916028
Khojasteh, S Cyrus, et al. "Novel advances in biotransformation and bioactivation research - 2020 year in review." Drug metabolism reviews vol. 53,3 (2021): 384-433. doi: https://doi.org/10.1080/03602532.2021.1916028
Khojasteh SC, Argikar UA, Driscoll JP, Heck CJS, King L, Jackson KD, Jian W, Kalgutkar AS, Miller GP, Kramlinger V, Rietjens IMCM, Teitelbaum AM, Wang K, Wei C. Novel advances in biotransformation and bioactivation research - 2020 year in review. Drug Metab Rev. 2021 Aug;53(3):384-433. doi: 10.1080/03602532.2021.1916028. Epub 2021 Jun 24. PMID: 33910427.
Copy Download .nbib Format: NLM
Mass Spectrometry Based Protein Biomarkers and Drug Target Discovery and Clinical Diagnosis in Age-Related Progressing Neurodegenerative Diseases.

Drug metabolism reviews

Agrawal I, Tripathi P, Biswas S.
PMID: 35038284
Drug Metab Rev. 2022 Jan 17;1-17. doi: 10.1080/03602532.2022.2029475. Epub 2022 Jan 17.

Neurodegenerative diseases correspond to overly complex health disorders that are driven by intersecting pathophysiology that are often trapped in vicious cycles of degeneration and cognitive decline. The usual diagnostic route of these diseases is based on postmortem examination that...

Cite
Agrawal I, Tripathi P, Biswas S. Mass Spectrometry Based Protein Biomarkers and Drug Target Discovery and Clinical Diagnosis in Age-Related Progressing Neurodegenerative Diseases. Drug Metab Rev. 2022;1-17doi: 10.1080/03602532.2022.2029475.
Agrawal, I., Tripathi, P., & Biswas, S. (2022). Mass Spectrometry Based Protein Biomarkers and Drug Target Discovery and Clinical Diagnosis in Age-Related Progressing Neurodegenerative Diseases. Drug metabolism reviews, 1-17. https://doi.org/10.1080/03602532.2022.2029475
Agrawal, Ishita, et al. "Mass Spectrometry Based Protein Biomarkers and Drug Target Discovery and Clinical Diagnosis in Age-Related Progressing Neurodegenerative Diseases." Drug metabolism reviews vol. (2022): 1-17. doi: https://doi.org/10.1080/03602532.2022.2029475
Agrawal I, Tripathi P, Biswas S. Mass Spectrometry Based Protein Biomarkers and Drug Target Discovery and Clinical Diagnosis in Age-Related Progressing Neurodegenerative Diseases. Drug Metab Rev. 2022 Jan 17;1-17. doi: 10.1080/03602532.2022.2029475. Epub 2022 Jan 17. PMID: 35038284.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 56 entries